Nymox PharmaceuticalNYMXF
13F holders, Q3 2024 (September 30)2holders +1
1new positions
0sold out
$0.12avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Nymox Pharmaceutical Corp. (NYMXF) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were DF Dent & Co. Inc. ($9K) and First Citizens Financial Corp ($4K).
- Company
- Nymox Pharmaceutical Corp.
- CUSIP
- P73398102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 75,000 shares bought, net +75,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| DF Dent & Co. Inc. | 0.00% | New | 75,000 | $9K |
| First Citizens Financial Corp | 0.00% | No change | 35,100 | $4K |
"% of holder's portfolio" is NYMXF's weight in each manager's 13F, not the share of Nymox Pharmaceutical Corp. the manager owns.